Drug name - Ortikos

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9707182 SUN PHARM INDS INC Oral pharmaceutical dosage forms of budesonide Sep, 2036

(13 years from now)

US10172802 SUN PHARM INDS INC Oral pharmaceutical dosage forms of budesonide Sep, 2036

(13 years from now)

Drugs and Companies using BUDESONIDE ingredient

Treatment: Treatment of mild to moderate active crohn's disease involving the ileum and/or the ascending colon

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
6MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
9MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.